About Unlearn.AI
Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer’s Disease, Multiple Sclerosis, and other complex diseases.
Website: Learn more on Unlearn.AI’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – Unlearn.AI
| Amount Raised | 3000000 USD |
| Announced Date | 2020-11-05 |
| Equity Only Funding | Yes |
| Organization Location | San Francisco, California, United States, North America |
| Funding Status | Early Stage Venture |
| Number of Funding Rounds | 2 |
| Lead Investors | |
| Number of Investors | 3 |
| Number of Partner Investors |
